We strongly believe in supporting the community in working closely with patient associations as our goal is to improve the health of Canadians living with diseases. AbbVie is fully committed to upholding the highest ethical standards regarding patient association funding, and our current process meets these standards. We also follow the Innovative Medicine Canada (IMC) Code of ethical practices. To learn more, we encourage you to visit section 3.3 - Guidelines for transparency in funding of patient and advocacy groups and patient associations (including annex A) from the 2018 Code of Ethical Practices document listed on the Innovative Medicines Canada Web site.
Some patient associations that receive support from AbbVie include:
You are now leaving the AbbVie.ca Web site. The AbbVie Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in Canada.
Do you wish to continue?
You are about to leave an AbbVie Canada site, a Web site maintained by AbbVie Corporation. This link is provided for your convenience only. AbbVie Corporation takes no responsibility for the content of any Web site maintained by any third party and makes no representation as to the accuracy or completeness of any information contained on this or any subsequent link.
Do you wish to leave this site?